Latest Posts

Meeting with the European Food safety Authority (EFSA)

On 18 January 2019, IPA Europe met with the European Food Safety Authority (EFSA) in Parma, Italy, for a scientific discussion. This enabled IPA Europe scientific experts to gain a better understanding of the EFSA role and remit, particularly with regard to scientific substantiation of health claims made on food. A debate also took place ...

9th International Akademie Fresenius Conference “Health Claims and Functional Ingredients”

Health claims and Functional Ingredients: several aspects of the Health Claims Regulations were presented during the Conference “Health Claims and Functional Ingredients” (link), hosted by  Akedemie Fresenius in Mainz (DE) on 4th and 5th June 2019. The conference’s structure was divided into three different panels: the Legal frame, Application and Authorisation, Nutrition and Functional Ingredients. ...

10th PROBIOTICS, PREBIOTICS NEW FOODS, NUTRACEUTICALS AND BOTANICALS for NUTRITION & HUMAN and MICROBIOTA HEALTH

On Monday 9th September 2019, Esbend Laulund, President IPA Europe, opened the session  “THE GLOBAL VOICE OF PROBIOTICS IPA/IPA EUROPE SESSION: How to define a comprehensive approach for the definition of the probiotic category (nutrition relevance and scientific requirements)”. With the help of the experts, we gathered to discuss issues pertaining to the interplay between ...

Workshop on “Probiotics and Innovation”

Over 45 representatives, including Member States’ authorities, stakeholders and the European Commission, attended the Workshop on “Probiotics and Innovation” organized in Brussels by the Permanent Representation of Denmark on 6 May. Read the Press Release Read the IPA Europe presentation ...

Clinical evidence and not microbiota outcomes drive value of probiotics

The International Scientific Association of Probiotics and Prebiotics (ISAPP), immediately reacted to the recent papers by Zmora, et al and Suez, et al, with scientific arguments to counter the inaccurate information on probiotics: Hundreds of human trials have demonstrated clinical benefits of probiotics and several evidence-based recommendations have been issued by medical organizations. This irresponsible ...

IPA Europe contends that the recent studies, questioning the health benefits of probiotics, basically confirm the knowledge that we already have on probiotics: namely that probiotic strains are indeed likely to have individual responses.

It is regrettable that, although the authors themselves state that the microbiota is influenced by very many factors and is extremely diverse, their ‘study group” consists of only 8 people, which is too small to be able to reliably evaluate so many parameters or to draw any far-reaching conclusions. Read the Press Release ...

A HUNDRED TRILLION REASONS TO CELEBRATE WORLD MICROBIOME DAY THE 27th OF JUNE

Our microbiota has been suggested to contribute to health in many areas including digestive health and immune health. This new, exciting research area focusses primarily around the gut microbiota. Moreover, several medical and scientific organisations have highly recommended, in their evidence-based guidelines, the use of probiotics to ameliorate gastrointestinal symptoms or diseases in children and ...

PROPOSAL ON “HARMONISED PROBIOTIC GUIDELINES FOR THE USE IN FOODS AND DIETARY SUPPLEMENTS” PRESENTED BY ARGENTINA AT THE 40TH MEETING OF THE CODEX COMMITTEE ON NUTRITION AND FOODS FOR SPECIAL DIETARY USES (CCNFSDU)

The Argentinian delegation introduced the Discussion Paper on “Harmonized Probiotic Guidelines for Use in Foods and Dietary Supplements” on 28 November in Berlin. IPA joined the group of National delegations supporting starting new work.   Read more ...